Literature DB >> 17603294

Exercise type and muscle fiber specific induction of caveolin-1 expression for insulin sensitivity of skeletal muscle.

Yoon Sin Oh1, Hyo Jeong Kim, Sung Jin Ryu, Kyung A Cho, Young Sik Park, Hyon Park, MiJung Kim, Chang Keun Kim, Sang Chul Park.   

Abstract

It is well known that exercise can have beneficial effects on insulin resistance by activation of glucose transporter. Following up our previous report that caveolin-1 plays an important role in glucose uptake in L6 skeletal muscle cells, we examined whether exercise alters the expression of caveolin-1, and whether exercise-caused changes are muscle fiber and exercise type specific. Fifty week-old Sprague Dawley (SD) rats were trained to climb a ladder and treadmill for 8 weeks and their soleus muscles (SOL) and extensor digitorum longus muscles (EDL) were removed after the last bout of exercise and compared with those from non-exercised animals. We found that the expression of insulin related proteins and caveolins did not change in SOL muscles after exercise. However, in EDL muscles, the expression of insulin receptor beta (IR beta) and glucose transporter-4 (GLUT-4) as well as phosphorylation of AKT and AMPK increased with resistance exercise but not with aerobic exercise. Also, caveolin-1 and caveolin-3 increased along with insulin related proteins only in EDL muscles by resistance exercise. These results suggest that upregulation of caveolin-1 in the skeletal muscle is fiber specific and exercise type specific, implicating the requirement of the specific mode of exercise to improve insulin sensitivity.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17603294     DOI: 10.1038/emm.2007.44

Source DB:  PubMed          Journal:  Exp Mol Med        ISSN: 1226-3613            Impact factor:   8.718


  8 in total

1.  MicroRNAs in hepatic pathophysiology in diabetes.

Authors:  Kirandeep Kaur; Himanshi Bhatia; Malabika Datta
Journal:  World J Diabetes       Date:  2011-10-15

2.  Modulation of insulin sensitivity and caveolin-1 expression by orchidectomy in a nonobese type 2 diabetes animal model.

Authors:  Yoon Sin Oh; Tae Sup Lee; Gi Jeong Cheon; Ik-Soon Jang; Hee-Sook Jun; Sang Chul Park
Journal:  Mol Med       Date:  2010-09-10       Impact factor: 6.354

3.  Caveolin, GLUT4 and insulin receptor protein content in human arm and leg muscles.

Authors:  Hyo Sik Kim; Hyo Jeong Kim; Young Sun Kim; Sang Chul Park; Roger Harris; Chang Keun Kim
Journal:  Eur J Appl Physiol       Date:  2009-02-14       Impact factor: 3.078

4.  A potential role for skeletal muscle caveolin-1 as an insulin sensitivity modulator in ageing-dependent non-obese type 2 diabetes: studies in a new mouse model.

Authors:  Y S Oh; L-Y Khil; K A Cho; S J Ryu; M K Ha; G J Cheon; T S Lee; J-W Yoon; H-S Jun; S C Park
Journal:  Diabetologia       Date:  2008-04-12       Impact factor: 10.122

5.  Differential expression of caveolins and myosin heavy chains in response to forced exercise in rats.

Authors:  Sookyoung Park; Yunkyung Hong; Youngjeon Lee; Jinyoung Won; Kyu-Tae Chang; Yonggeun Hong
Journal:  Lab Anim Res       Date:  2012-03-21

6.  GDM-Induced Macrosomia Is Reversed by Cav-1 via AMPK-Mediated Fatty Acid Transport and GLUT1-Mediated Glucose Transport in Placenta.

Authors:  Guo Yao; Yafang Zhang; Di Wang; Ruirui Yang; Hui Sang; Linlin Han; Yuexia Zhu; Yanyan Lu; Yeke Tan; Zhanping Shang
Journal:  PLoS One       Date:  2017-01-26       Impact factor: 3.240

7.  Association between muscle strength and advanced fibrosis in non-alcoholic fatty liver disease: a Korean nationwide survey.

Authors:  Sunyoung Kang; Min Kyong Moon; Won Kim; Bo Kyung Koo
Journal:  J Cachexia Sarcopenia Muscle       Date:  2020-07-07       Impact factor: 12.910

8.  Exercise-Induced Changes in Caveolin-1, Depletion of Mitochondrial Cholesterol, and the Inhibition of Mitochondrial Swelling in Rat Skeletal Muscle but Not in the Liver.

Authors:  Damian Jozef Flis; Robert Antoni Olek; Jan Jacek Kaczor; Ewa Rodziewicz; Malgorzata Halon; Jedrzej Antosiewicz; Michal Wozniak; Rosita Gabbianelli; Wieslaw Ziolkowski
Journal:  Oxid Med Cell Longev       Date:  2015-12-29       Impact factor: 6.543

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.